Randomised controlled trial of tailored support to increase physical activity and reduce smoking in smokers not immediately ready to quit: protocol for the Trial of physical Activity-assisted Reduction of Smoking (TARS) Study

Adrian Taylor; Tom P Thompson; Michael Ussher; Paul Aveyard; Rachael L Murray; Tess Harris; Siobhan Creanor; Colin Green; Adam Justin Streeter; Jade Chynoweth; Wendy Ingram; Colin J Greaves; Helen Hancocks; Tristan Snowsill; Lynne Callaghan; Lisa Price; Jane Horrell; Jennie King; Alex Gude; Mary George; Charlotte Wahlich; Louisa Hamilton; Kelisha Cheema; Sarah Campbell; Dan Preece

doi:10.1136/bmjopen-2020-043331

Randomised controlled trial of tailored support to increase physical activity and reduce smoking in smokers not immediately ready to quit: protocol for the Trial of physical Activity-assisted Reduction of Smoking (TARS) Study

Adrian Taylor, Tom P Thompson, Michael Ussher, Paul Aveyard, Rachael L Murray, Tess Harris, Siobhan Creanor, Colin Green, Adam Justin Streeter, Jade Chynoweth, Wendy Ingram, Colin J Greaves, Helen Hancocks, Tristan Snowsill, Lynne Callaghan, Lisa Price, Jane Horrell, Jennie King, Alex Gude, Mary GeorgeCharlotte Wahlich, Louisa Hamilton, Kelisha Cheema, Sarah Campbell, Dan Preece

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

INTRODUCTION: Smoking reduction can lead to increased success in quitting. This study aims to determine if a client-focused motivational support package for smoking reduction (and quitting) and increasing (or otherwise using) physical activity (PA) can help smokers who do not wish to quit immediately to reduce the amount they smoke, and ultimately quit. This paper reports the study design and methods.

METHODS AND ANALYSIS: A pragmatic, multicentred, parallel, two group, randomised controlled superiority clinical trial, with embedded process evaluation and economics evaluation. Participants who wished to reduce smoking with no immediate plans to quit were randomised 1:1 to receive either (1) tailored individual health trainer face-to-face and/or telephone support to reduce smoking and increase PA as an aid to smoking reduction (intervention) or (2) brief written/electronic advice to reduce or quit smoking (control). Participants in both arms of the trial were also signposted to usual local support for smoking reduction and quitting. The primary outcome measure is 6-month carbon monoxide-confirmed floating prolonged abstinence following participant self-reported quitting on a mailed questionnaire at 3 and 9 months post-baseline. Participants confirmed as abstinent at 9 months will be followed up at 15 months.

ETHICS AND DISSEMINATION: Approved by SW Bristol National Health Service Research Committee (17/SW/0223). Dissemination will include publication of findings for the stated outcomes, parallel process evaluation and economic evaluation in peer-reviewed journals. Results will be disseminated to trial participants and healthcare providers.

TRIAL REGISTRATION NUMBER: ISRCTN47776579; Pre-results.

Original language	English
Pages (from-to)	e043331
Journal	BMJ open
Volume	10
Issue number	12
DOIs	https://doi.org/10.1136/bmjopen-2020-043331
Publication status	Published - 1 Dec 2020

Access to Document

10.1136/bmjopen-2020-043331

Fingerprint

Dive into the research topics of 'Randomised controlled trial of tailored support to increase physical activity and reduce smoking in smokers not immediately ready to quit: protocol for the Trial of physical Activity-assisted Reduction of Smoking (TARS) Study'. Together they form a unique fingerprint.

Cite this

Taylor, A., Thompson, T. P., Ussher, M., Aveyard, P., Murray, R. L., Harris, T., Creanor, S., Green, C., Streeter, A. J., Chynoweth, J., Ingram, W., Greaves, C. J., Hancocks, H., Snowsill, T., Callaghan, L., Price, L., Horrell, J., King, J., Gude, A., ... Preece, D. (2020). Randomised controlled trial of tailored support to increase physical activity and reduce smoking in smokers not immediately ready to quit: protocol for the Trial of physical Activity-assisted Reduction of Smoking (TARS) Study. BMJ open, 10(12), e043331. https://doi.org/10.1136/bmjopen-2020-043331

@article{0e284d199ce84ff69ac25b4ae73d2f7a,

title = "Randomised controlled trial of tailored support to increase physical activity and reduce smoking in smokers not immediately ready to quit: protocol for the Trial of physical Activity-assisted Reduction of Smoking (TARS) Study",

abstract = "INTRODUCTION: Smoking reduction can lead to increased success in quitting. This study aims to determine if a client-focused motivational support package for smoking reduction (and quitting) and increasing (or otherwise using) physical activity (PA) can help smokers who do not wish to quit immediately to reduce the amount they smoke, and ultimately quit. This paper reports the study design and methods.METHODS AND ANALYSIS: A pragmatic, multicentred, parallel, two group, randomised controlled superiority clinical trial, with embedded process evaluation and economics evaluation. Participants who wished to reduce smoking with no immediate plans to quit were randomised 1:1 to receive either (1) tailored individual health trainer face-to-face and/or telephone support to reduce smoking and increase PA as an aid to smoking reduction (intervention) or (2) brief written/electronic advice to reduce or quit smoking (control). Participants in both arms of the trial were also signposted to usual local support for smoking reduction and quitting. The primary outcome measure is 6-month carbon monoxide-confirmed floating prolonged abstinence following participant self-reported quitting on a mailed questionnaire at 3 and 9 months post-baseline. Participants confirmed as abstinent at 9 months will be followed up at 15 months.ETHICS AND DISSEMINATION: Approved by SW Bristol National Health Service Research Committee (17/SW/0223). Dissemination will include publication of findings for the stated outcomes, parallel process evaluation and economic evaluation in peer-reviewed journals. Results will be disseminated to trial participants and healthcare providers.TRIAL REGISTRATION NUMBER: ISRCTN47776579; Pre-results.",

author = "Adrian Taylor and Thompson, {Tom P} and Michael Ussher and Paul Aveyard and Murray, {Rachael L} and Tess Harris and Siobhan Creanor and Colin Green and Streeter, {Adam Justin} and Jade Chynoweth and Wendy Ingram and Greaves, {Colin J} and Helen Hancocks and Tristan Snowsill and Lynne Callaghan and Lisa Price and Jane Horrell and Jennie King and Alex Gude and Mary George and Charlotte Wahlich and Louisa Hamilton and Kelisha Cheema and Sarah Campbell and Dan Preece",

note = "{\textcopyright} Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.",

year = "2020",

month = dec,

day = "1",

doi = "10.1136/bmjopen-2020-043331",

language = "English",

volume = "10",

pages = "e043331",

journal = "BMJ open",

issn = "2044-6055",

publisher = "BMJ Publishing Group",

number = "12",

}

Taylor, A, Thompson, TP, Ussher, M, Aveyard, P, Murray, RL, Harris, T, Creanor, S, Green, C, Streeter, AJ, Chynoweth, J, Ingram, W, Greaves, CJ, Hancocks, H, Snowsill, T, Callaghan, L, Price, L, Horrell, J, King, J, Gude, A, George, M, Wahlich, C, Hamilton, L, Cheema, K, Campbell, S & Preece, D 2020, 'Randomised controlled trial of tailored support to increase physical activity and reduce smoking in smokers not immediately ready to quit: protocol for the Trial of physical Activity-assisted Reduction of Smoking (TARS) Study', BMJ open, vol. 10, no. 12, pp. e043331. https://doi.org/10.1136/bmjopen-2020-043331

Randomised controlled trial of tailored support to increase physical activity and reduce smoking in smokers not immediately ready to quit: protocol for the Trial of physical Activity-assisted Reduction of Smoking (TARS) Study. / Taylor, Adrian; Thompson, Tom P; Ussher, Michael et al.
In: BMJ open, Vol. 10, No. 12, 01.12.2020, p. e043331.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Randomised controlled trial of tailored support to increase physical activity and reduce smoking in smokers not immediately ready to quit

T2 - protocol for the Trial of physical Activity-assisted Reduction of Smoking (TARS) Study

AU - Taylor, Adrian

AU - Thompson, Tom P

AU - Ussher, Michael

AU - Aveyard, Paul

AU - Murray, Rachael L

AU - Harris, Tess

AU - Creanor, Siobhan

AU - Green, Colin

AU - Streeter, Adam Justin

AU - Chynoweth, Jade

AU - Ingram, Wendy

AU - Greaves, Colin J

AU - Hancocks, Helen

AU - Snowsill, Tristan

AU - Callaghan, Lynne

AU - Price, Lisa

AU - Horrell, Jane

AU - King, Jennie

AU - Gude, Alex

AU - George, Mary

AU - Wahlich, Charlotte

AU - Hamilton, Louisa

AU - Cheema, Kelisha

AU - Campbell, Sarah

AU - Preece, Dan

PY - 2020/12/1

Y1 - 2020/12/1

N2 - INTRODUCTION: Smoking reduction can lead to increased success in quitting. This study aims to determine if a client-focused motivational support package for smoking reduction (and quitting) and increasing (or otherwise using) physical activity (PA) can help smokers who do not wish to quit immediately to reduce the amount they smoke, and ultimately quit. This paper reports the study design and methods.METHODS AND ANALYSIS: A pragmatic, multicentred, parallel, two group, randomised controlled superiority clinical trial, with embedded process evaluation and economics evaluation. Participants who wished to reduce smoking with no immediate plans to quit were randomised 1:1 to receive either (1) tailored individual health trainer face-to-face and/or telephone support to reduce smoking and increase PA as an aid to smoking reduction (intervention) or (2) brief written/electronic advice to reduce or quit smoking (control). Participants in both arms of the trial were also signposted to usual local support for smoking reduction and quitting. The primary outcome measure is 6-month carbon monoxide-confirmed floating prolonged abstinence following participant self-reported quitting on a mailed questionnaire at 3 and 9 months post-baseline. Participants confirmed as abstinent at 9 months will be followed up at 15 months.ETHICS AND DISSEMINATION: Approved by SW Bristol National Health Service Research Committee (17/SW/0223). Dissemination will include publication of findings for the stated outcomes, parallel process evaluation and economic evaluation in peer-reviewed journals. Results will be disseminated to trial participants and healthcare providers.TRIAL REGISTRATION NUMBER: ISRCTN47776579; Pre-results.

AB - INTRODUCTION: Smoking reduction can lead to increased success in quitting. This study aims to determine if a client-focused motivational support package for smoking reduction (and quitting) and increasing (or otherwise using) physical activity (PA) can help smokers who do not wish to quit immediately to reduce the amount they smoke, and ultimately quit. This paper reports the study design and methods.METHODS AND ANALYSIS: A pragmatic, multicentred, parallel, two group, randomised controlled superiority clinical trial, with embedded process evaluation and economics evaluation. Participants who wished to reduce smoking with no immediate plans to quit were randomised 1:1 to receive either (1) tailored individual health trainer face-to-face and/or telephone support to reduce smoking and increase PA as an aid to smoking reduction (intervention) or (2) brief written/electronic advice to reduce or quit smoking (control). Participants in both arms of the trial were also signposted to usual local support for smoking reduction and quitting. The primary outcome measure is 6-month carbon monoxide-confirmed floating prolonged abstinence following participant self-reported quitting on a mailed questionnaire at 3 and 9 months post-baseline. Participants confirmed as abstinent at 9 months will be followed up at 15 months.ETHICS AND DISSEMINATION: Approved by SW Bristol National Health Service Research Committee (17/SW/0223). Dissemination will include publication of findings for the stated outcomes, parallel process evaluation and economic evaluation in peer-reviewed journals. Results will be disseminated to trial participants and healthcare providers.TRIAL REGISTRATION NUMBER: ISRCTN47776579; Pre-results.

U2 - 10.1136/bmjopen-2020-043331

DO - 10.1136/bmjopen-2020-043331

M3 - Article

C2 - 33262194

SN - 2044-6055

VL - 10

SP - e043331

JO - BMJ open

JF - BMJ open

IS - 12

ER -